About This Treatment Guide

Article

About This Treatment Guide

The Oncology Group of CMPMedica, publisher of ONCOLOGY and Oncology NEWS International, and the website, cancernetwork.com, is pleased to present Cancer Management: A Multidisciplinary Approach, 11th edition. Cancer Management: A Multidisciplinary Approach is designed to present important clinical information concisely, uniformly, and logically, emphasizing the natural history of the malignancy, screening and diagnosis, staging and prognosis, and treatment.

The fundamental principle behind this comprehensive treatment guide is the importance of a truly integrated, multidisciplinary approach to the management of the patient with cancer. Accordingly, the discussion of each disease site combines the perspectives of medical oncology, surgical oncology, and radiation oncology, as appropriate. Further, each of the book’s medical editors represent a particular discipline.

The Oncology Group would like to thank the contributors and all involved in the development and production of this important handbook. In particular, we thank the book’s principal editors:

 

Richard Pazdur, MD

(Medical Oncology)
US Food and Drug Administration

Lawrence D. Wagman, MD

(Surgical Oncology)
Center for Cancer Prevention and Treatment, St. Joseph Hospital

Kevin A. Camphausen, MD

(Radiation Oncology)
National Cancer Institute

William J. Hoskins, MD

(Gynecologic Oncology)
Memorial Sloan-Kettering Cancer Center


We also thank the staff of The Oncology Group and in particular wish to recognize the efforts of Angela Cibuls and Susan Reckling.

This 11th edition has been produced in an effort to keep pace with the rapidly changing field of oncology. Be sure to visit www.cancernetwork.com, where the full text of this edition will be made available online, with important updates as appropriate.

Please let us know how you use this book, and how we can make it even more valuable. We look forward to hearing from you.

Sincerely,

Cara H. Glynn
Beth Scholz

 

 

Recent Videos
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content